Merck’s Zostavax Shingles Vaccine Approved
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved the herpes zoster vaccine for patients ages 60 years and older.
You may also be interested in...
Merck’s Gardasil HPV Vaccine Clears FDA
The vaccine, which is administered in a three-dose series, is available for ordering at $120 per dose, Merck says.
Merck’s Gardasil HPV Vaccine Clears FDA
The vaccine, which is administered in a three-dose series, is available for ordering at $120 per dose, Merck says.
Merck Zostavax Shingles Vaccine Safe and Effective For Adults Over 60, Committee Says
FDA's Vaccines & Related Biological Products Advisory Committee said data do not support Merck's proposed indication for adults as young as 50 years.